NO20042781L - Farmasoytiske sammensetninger basert pa azetidinderivater - Google Patents

Farmasoytiske sammensetninger basert pa azetidinderivater

Info

Publication number
NO20042781L
NO20042781L NO20042781A NO20042781A NO20042781L NO 20042781 L NO20042781 L NO 20042781L NO 20042781 A NO20042781 A NO 20042781A NO 20042781 A NO20042781 A NO 20042781A NO 20042781 L NO20042781 L NO 20042781L
Authority
NO
Norway
Prior art keywords
azetidine
general formula
optionally
azetidine derivative
pharmaceutical compositions
Prior art date
Application number
NO20042781A
Other languages
English (en)
Norwegian (no)
Inventor
Sophie Cote
Bobineau Valerie
Peracchia Maria-Teresa
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20042781L publication Critical patent/NO20042781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20042781A 2001-12-21 2004-07-01 Farmasoytiske sammensetninger basert pa azetidinderivater NO20042781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116638A FR2833842B1 (fr) 2001-12-21 2001-12-21 Compositions pharmaceutiques a base de derives d'azetidine
PCT/FR2002/004514 WO2003053431A2 (fr) 2001-12-21 2002-12-20 Compositions pharmaceutiques a base de derives d'azetidine

Publications (1)

Publication Number Publication Date
NO20042781L true NO20042781L (no) 2004-09-20

Family

ID=8870824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042781A NO20042781L (no) 2001-12-21 2004-07-01 Farmasoytiske sammensetninger basert pa azetidinderivater

Country Status (31)

Country Link
EP (1) EP1458413B1 (de)
JP (1) JP5021887B2 (de)
KR (1) KR20040068308A (de)
CN (1) CN100388918C (de)
AP (1) AP1754A (de)
AR (1) AR037687A1 (de)
AU (1) AU2002364866B2 (de)
BR (1) BR0215048A (de)
CA (1) CA2470443A1 (de)
CO (1) CO5590911A2 (de)
DE (1) DE60233071D1 (de)
DK (1) DK1458413T3 (de)
EA (1) EA006510B1 (de)
EC (1) ECSP045162A (de)
FR (1) FR2833842B1 (de)
HR (1) HRP20040575A2 (de)
HU (1) HUP0402586A3 (de)
IL (1) IL162563A0 (de)
MA (1) MA27086A1 (de)
ME (1) MEP16608A (de)
MX (1) MXPA04005558A (de)
MY (1) MY138172A (de)
NO (1) NO20042781L (de)
NZ (1) NZ533225A (de)
OA (1) OA12750A (de)
PL (1) PL203248B1 (de)
RS (1) RS55504A (de)
TW (1) TWI256304B (de)
UA (1) UA77736C2 (de)
WO (1) WO2003053431A2 (de)
ZA (1) ZA200404338B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498123A1 (de) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulgierende Systeme enthaltend Azetidin Derivate
EP1498122A1 (de) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Halbfeste Systeme enthaltend Azetidin-Derivate
JP2007522255A (ja) 2004-02-17 2007-08-09 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ 置換アゼチジン化合物、その製造および医薬品としての使用
FR2879932B1 (fr) * 2004-12-27 2007-03-23 Aventis Pharma Sa Formulations injectable ou administrable par voie orale de derives d'azetidine
MX2007016508A (es) 2005-06-30 2008-03-04 Prosidion Ltd Agonistas del receptor acoplado a la proteina g.
US20100048625A1 (en) 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine gpcr agonists
PE20081849A1 (es) 2007-01-04 2009-01-26 Prosidion Ltd Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
US20100048632A1 (en) 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine GPCR Agonists
PE20081659A1 (es) 2007-01-04 2008-10-24 Prosidion Ltd Agonistas de gpcr
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
FR2928149B1 (fr) 2008-02-29 2011-01-14 Sanofi Aventis Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2946650B1 (fr) * 2009-06-16 2011-08-19 Sanofi Aventis Esters derives d'azetidines, leur preparation et leur application en therapeutique.
UA153183U (uk) 2022-10-27 2023-05-31 Андрій Валерійович Максимов Стаканчик для приготування напою

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73668B (de) * 1978-11-21 1984-03-28 Hoffmann La Roche
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) * 1998-01-20 1999-10-31 Pliva Pharm & Chem Works 1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
JP2002520377A (ja) * 1998-07-14 2002-07-09 イーエム インダストリーズ インコーポレイテッド ミクロ分散薬物送達システム
FR2783246B1 (fr) * 1998-09-11 2000-11-17 Aventis Pharma Sa Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2805810B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

Also Published As

Publication number Publication date
TWI256304B (en) 2006-06-11
PL372708A1 (en) 2005-07-25
PL203248B1 (pl) 2009-09-30
MY138172A (en) 2009-04-30
CN1602206A (zh) 2005-03-30
CN100388918C (zh) 2008-05-21
HUP0402586A2 (hu) 2005-03-29
EA006510B1 (ru) 2005-12-29
MEP16608A (en) 2010-06-10
IL162563A0 (en) 2005-11-20
WO2003053431A3 (fr) 2003-12-18
RS55504A (sr) 2007-06-04
MA27086A1 (fr) 2004-12-20
ZA200404338B (en) 2005-06-02
NZ533225A (en) 2007-02-23
HK1070840A1 (zh) 2005-06-30
OA12750A (fr) 2006-07-03
WO2003053431A2 (fr) 2003-07-03
CO5590911A2 (es) 2005-12-30
JP2005516945A (ja) 2005-06-09
CA2470443A1 (fr) 2003-07-03
EP1458413A2 (de) 2004-09-22
EP1458413B1 (de) 2009-07-22
DK1458413T3 (da) 2009-11-23
ECSP045162A (es) 2004-08-27
AP1754A (en) 2007-07-18
HUP0402586A3 (en) 2011-05-30
AU2002364866B2 (en) 2006-11-30
KR20040068308A (ko) 2004-07-30
HRP20040575A2 (en) 2004-10-31
AU2002364866A1 (en) 2003-07-09
EA200400843A1 (ru) 2004-12-30
AR037687A1 (es) 2004-12-01
UA77736C2 (en) 2007-01-15
FR2833842B1 (fr) 2004-02-13
BR0215048A (pt) 2004-11-03
DE60233071D1 (de) 2009-09-03
TW200301108A (en) 2003-07-01
JP5021887B2 (ja) 2012-09-12
AP2004003066A0 (en) 2004-06-30
FR2833842A1 (fr) 2003-06-27
MXPA04005558A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
NO20042781L (no) Farmasoytiske sammensetninger basert pa azetidinderivater
NO20045072L (no) Tablett med hoyt medikamentinnhold
NO20052335L (no) Dispergerbare deferacirox-tabletter
JP2004501930A5 (de)
DE60017582D1 (de) Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
SE0302760D0 (sv) New compounds
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
NO20026094L (no) Kondenserte azepinderivater og deres anvendelse som antidiuretiske midler
NO20082265L (no) Dispergerbare tabletter som innbefatter deferasirox
NO20084744L (no) Trisubstituerte 1,2,4-triazoler
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
MA53927B1 (fr) Composition pharmaceutique pour une administration par voie orale comprenant un dérivé d'aminopyrimidine ou son sel
HRP20110162A8 (hr) Spojevi koji sadrže amlodipin i bisoprolol
PH12022552454A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof
JP2000159790A5 (de)
WO2002060423A3 (en) Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
NO20014864D0 (no) Substituerte 1,4-dihydro-inden [1,2-C] pyrazoler som inhibitorer av tyrosin kinase
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
EP1813270A4 (de) Proteininhibitoren der hsp90-familie
MY142739A (en) Carbostyril derivatives for accelerating salivation
NO20063858L (no) Antimikrobielle preservativer for oppnaelse av en multidoseformulering ved bruk av beta-cyklodekstriner for flytende doseringsformer
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
WO2003070153A3 (en) Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application